Risk-based classification of hypertension and the role of combination therapy.
about
Prognostic significance of the morning blood pressure surge in clinical practice: a systematic review.Appetite suppressants, cardiac valve disease and combination pharmacotherapyBeta-blockers in the treatment of hypertension: are there clinically relevant differences?Single-pill combination of amlodipine and valsartan in the management of hypertension.A randomized trial of the efficacy and safety of azilsartan medoxomil combined with chlorthalidone
P2860
Risk-based classification of hypertension and the role of combination therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Risk-based classification of hypertension and the role of combination therapy.
@en
Risk-based classification of hypertension and the role of combination therapy.
@nl
type
label
Risk-based classification of hypertension and the role of combination therapy.
@en
Risk-based classification of hypertension and the role of combination therapy.
@nl
prefLabel
Risk-based classification of hypertension and the role of combination therapy.
@en
Risk-based classification of hypertension and the role of combination therapy.
@nl
P2860
P1476
Risk-based classification of hypertension and the role of combination therapy.
@en
P2093
Matthew R Weir
P2860
P356
10.1111/J.1524-6175.2007.08134.X
P433
P577
2008-01-01T00:00:00Z